John Beshai to Cost-Benefit Analysis
This is a "connection" page, showing publications John Beshai has written about Cost-Benefit Analysis.
Connection Strength
0.049
-
Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure. Heart. 2016 11 01; 102(21):1742-1749.
Score: 0.028
-
HRS/ACCF expert consensus statement on pacemaker device and mode selection. J Am Coll Cardiol. 2012 Aug 14; 60(7):682-703.
Score: 0.021